Return to homepagePandemic Pact

Identification of antiviral drugs inhibiting the replication of COVID-19 (SARS-CoV-2) virus

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $795,840.8

  • Funder

    UFM Denmark

  • Principal Investigator

    Professor Jens Bukh

  • Research Location

    Denmark

  • Lead Research Institution

    Department of Immunology and Microbiology (ISIM), Faculty of Health and Medical Sciences, University of Copenhagen

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The project investigates the activity of existing drugs against the COVID-19 (SARS- CoV-2) virus, with focus on broad-spectrum antivirals that inhibit viral replication. The studied compounds were developed to treat other viral diseases and have been found to be safe in humans, ensuring a rapid translation for the treatment of patients with COVID-19.